Extensive brain pathology in a patient with aceruloplasminemia with a prolonged duration of illness

Human Pathology

Volumn 43, Issue 3, 2012, Pages 451-456

  Kaneko, Kazuma ^a   Hineno, Akiyo ^a   Yoshida, Kunihiro ^a   Ohara, Shinji ^b   Morita, Hiroshi ^a   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Matsumoto Hospital   (Japan)

Author keywords

Astrocyte; Ceruloplasmin; Ferroxidase; Globular structure; Iron

Indexed keywords

CERULOPLASMIN;

ACERULOPLASMINEMIA; ADULT; ARTICLE; ASTROCYTE; AUTOPSY; BASAL GANGLION; BRAIN CORTEX; BRAIN DISEASE; CERULOPLASMIN BLOOD LEVEL; CORRELATION COEFFICIENT; DISEASE DURATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEUROPATHOLOGY; PYRAMIDAL NERVE CELL;

BASAL GANGLIA; BRAIN DISEASES; BRONCHOPNEUMONIA; CEREBELLAR NUCLEI; CEREBRAL CORTEX; CERULOPLASMIN; FATAL OUTCOME; HUMANS; IRON; IRON METABOLISM DISORDERS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; TIME FACTORS;

EID: 84857048845     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.05.016     Document Type: Article

References (15)

1. B. Halliwell Oxidative stress and neurodegeneration: where are we now? J Neurochem 97 2006 1634 1658 (Pubitemid 43873658)
2. L. Zecca, M.B.H. Youdim, and P. Riederer Iron, brain ageing and neurodegenerative disorders Nat Rev Neurosci 5 2004 863 873 (Pubitemid 39482155)
3. T. Moos, T.R. Nielsen, and T. Skjørringe Iron trafficking inside the brain J Neurochem 103 2007 1730 1740 (Pubitemid 350126643)
4. E.E. Benarroch Brain iron homeostasis and neurodegenerative disease Neurology 72 2009 1436 1440
5. H. Miyajima, Y. Nishimura, and K. Mizoguchi Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration Neurology 37 1987 761 767 (Pubitemid 17064662)
6. H. Morita, S. Ikeda, and K. Yamamoto Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family Ann Neurol 37 1995 646 656
7. K. Yoshida, K. Kaneko, and H. Miyajima Increased lipid peroxidation in the brains of aceruloplasminemia patients J Neurol Sci 175 2000 91 95 (Pubitemid 30265474)
8. K. Kaneko, A. Nakamura, and K. Yoshida Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain Free Radic Res 36 2002 303 306 (Pubitemid 35154074)
9. T. Oide, K. Yoshida, and K. Kaneko Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia Neuropath App Neurol 32 2006 170 176
10. K. Kaneko, K. Yoshida, and K. Arima Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia J Neuropathol Exp Neurol 61 2002 1069 1077 (Pubitemid 35435025)
11. K. Yoshida, K. Furihata, and S. Takeda A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans Nat Genet 9 1995 267 272
12. A. Fasano, C. Colosimo, and H. Miyajima Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability Mov Disord 23 2008 151 155
13. C.A. Rottkamp, A.K. Raina, and X. Zhu Redox-active iron iron mediates amyloid-β toxicity Free Radic Biol Med 30 2001 447 450 (Pubitemid 32155543)
14. N. Ostrerova-Golts, L. Petrucelli, and J. Hardy The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity J Neurosci 20 2000 6048 6054 (Pubitemid 30658398)
15. S. Magaki, R. Raghavan, and C. Mueller Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias Neurosci Lett 418 2007 72 76 (Pubitemid 46602696)